The Riboscience leadership team has over 50 years of combined expertise that spans the research and development spectrum, from drug discovery and development to drug approval, and beyond.
Klaus Klumpp
Founder and President
Jeffrey Glenn
Founder, Virology and Strategy
Mark Smith
Founder
Peter Crnkovich
Financial and Strategic Advisor